Edition:
India

Aptevo Therapeutics Reports Q1 Loss Per Share $0.44


Thursday, 9 May 2019 

May 9 (Reuters) - Aptevo Therapeutics Inc ::APTEVO THERAPEUTICS REPORTS FIRST QUARTER 2019 FINANCIAL RESULTS.Q1 LOSS PER SHARE $0.44.ON TARGET FOR LAUNCH OF NEW 3,000 IU IXINITY ASSAY MID-2019.APTEVO THERAPEUTICS- ADVANCES ENROLLMENT IN APVO436 & APVO210 PHASE 1 CLINICAL STUDIES; SEES TOP-LINE PRELIMINARY DATA READ-OUTS IN Q3 & Q4 2019.APTEVO HAD CASH, CASH EQUIVALENTS, AND MARKETABLE SECURITIES AS OF MARCH 31, 2019 TOTALING $44.5 MILLION. 

Company Quote

0.618
0.0178 +2.97%
9 Dec 2019